LiveOne, Inc. Form 8-K Summary
Business Context and Reporting Period
LiveOne, Inc. (LVO) filed this Current Report on Form 8-K on July 17, 2025, to disclose the closing of a public equity offering. The company is incorporated in Delaware and trades on the NASDAQ Capital Market.
Key Financial Metrics and Transaction Details
- Transaction Type: Underwritten public offering of common stock.
- Shares Issued: 13,608,334 shares of common stock at an offering price of $0.75 per share.
- Over-Allotment Option: The underwriter was granted an option to purchase up to 1,775,000 additional shares, which was exercised.
- Gross Proceeds: Approximately $9.5 million (inclusive of the option exercise).
- Underwriting Discount: 7% of the public offering price.
- Warrants Issued: Warrants to purchase up to 4% of the securities sold in the offering at an exercise price of $0.9375.
- Net Proceeds: The filing text does not provide a clear value for net proceeds after deducting offering expenses.
Material Changes
This filing represents a material change in the company's capital structure due to the issuance of new equity. The transaction closed on July 17, 2025, following the entry into the underwriting agreement on July 15, 2025. No prior period financial metrics (revenue, profit, cash flow) are provided in this specific filing.
Outlook, Risks, and Management Commentary
The filing confirms the successful closing of the offering. Management commentary is limited to the confirmation of the transaction terms and the closing date. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard terms of the underwriting agreement.
Key Facts for Investor Verification
- Verify the exact number of shares issued and the total gross proceeds of $9.5 million in the company's subsequent financial statements.
- Confirm the dilution impact on existing shareholders resulting from the issuance of 13,608,334 shares plus the 1,775,000 option shares.
- Review the specific terms of the warrants issued (4% of securities sold) and their potential future dilution at the $0.9375 exercise price.
- Check for the disclosure of total offering expenses to calculate the precise net cash inflow to the company.